recro_logo.jpg
Recro Pharma Reports Third Quarter 2014 Financial Results
November 10, 2014 07:00 ET | Recro Pharma, Inc.
MALVERN, Pa., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain,...
recro_logo.jpg
Recro Pharma Announces Dosing of First Patient in Phase II REC-14-013 Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery
October 29, 2014 16:05 ET | Recro Pharma, Inc.
MALVERN, Pa., Oct. 29, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain,...
recro_logo.jpg
Recro Pharma to Present at the 2014 Aegis Healthcare & Technology Conference
September 08, 2014 07:00 ET | Recro Pharma, Inc.
MALVERN, Pa., Sept. 8, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain,...
recro_logo.jpg
Recro Pharma Provides Clinical Strategy Update Following Interim Analysis for Phase IIb Clinical Trial of Dex-IN
September 04, 2014 16:51 ET | Recro Pharma, Inc.
Analgesia in a subset of patients (50%), suggests therapeutic potential for Dex-IN in Post Op Day 1 Trial not expected to reach statistical significance as single agent on Post Op Day 0...
recro_logo.jpg
Recro Pharma Reports Second Quarter 2014 Financial Results
August 12, 2014 07:00 ET | Recro Pharma, Inc.
MALVERN, Pa., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain,...
recro_logo.jpg
Recro Pharma Added to Russell Microcap(R) Index
June 30, 2014 07:00 ET | Recro Pharma, Inc.
MALVERN, Pa., June 30, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain,...
recro_logo.jpg
Recro Pharma Announces Dosing of First Patient in Phase IIb Clinical Trial of Dex-IN for Treatment of Acute Pain Following Surgery
June 17, 2014 07:30 ET | Recro Pharma, Inc.
MALVERN, Pa., June 17, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain,...
recro_logo.jpg
Recro Pharma Reports First Quarter 2014 Financial Results
May 12, 2014 07:30 ET | Recro Pharma, Inc.
MALVERN, Pa., May 12, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain,...
recro_logo.jpg
Recro Pharma Announces New Board Members
March 13, 2014 13:23 ET | Recro Pharma, Inc.
MALVERN, Pa., March 13, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for post-operative pain, today...
recro_logo.jpg
Recro Pharma Announces Closing of Initial Public Offering
March 12, 2014 16:05 ET | Recro Pharma, Inc.
MALVERN, Pa., March 12, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain, today...